One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
ﻗﯿﻤﺖ : 300$- ﻗﯿﻤﺖ ﻭﯾﮋﻩ : 100$
Turning policy into action for brain health
doi : 10.1016/S1474-4422(25)00391-6
Volume 25, Issue 1, January 2026,
Exploring immunomodulation with azathioprine in Parkinson's disease
Advances in understanding sudden unexpected death in people with drug-resistant epilepsy
New diagnostic and therapeutic advancements for dementia in 2025
Epilepsy research in 2025: sudden unexpected death in epilepsy, artifical intelligence and seizure classification
Movement disorders in 2025: advances in early diagnosis and personalised treatment
Multiple sclerosis research in 2025: earlier diagnosis and halting progression
Advances in pain research in 2025 illuminate the complexities of neuropathic pain
Global equity needed for immunological disorders of the nervous system
Azathioprine for the treatment of early Parkinson's disease (AZA-PD): a randomised, double-blind, placebo-controlled, proof-of-concept, phase 2 trial
Seizure-related biomarkers of sudden unexpected death in epilepsy (SUDEP) in drug-resistant focal epilepsy (REPO2MSE): a prospective, multicentre case–control study
Endovascular thrombectomy for acute stroke: evolving eligibility criteria and adjunct therapies
Emerging technologies and strategies in epilepsy surgery: toward personalised medicine
The role of lifestyle interventions in symptom management and disease modification in Parkinson's disease
The gut microbiome, systemic inflammation, and autoimmunity in Parkinson's disease
